Detalles de la búsqueda
1.
Efficacy and safety of recombinant Mycobacterium tuberculosis ESAT-6 protein for diagnosis of pulmonary tuberculosis: a phase II trial.
Med Sci Monit
; 19: 969-77, 2013 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24217560
2.
[The effect of various antigen compounds of tuberculosis composite antigen vaccine on the immune function in mice].
Zhonghua Jie He He Hu Xi Za Zhi
; 34(4): 269-73, 2011 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-21609610
3.
[Preparation of two antigens--Ag85b and HspX of Mycobacterium tuberculosis H37Rv and the effects of their co-administration with adjuvants in mice].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 31(4): 403-9, 2009 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-19771723
4.
Recombinant tuberculosis vaccine AEC/BC02 induces antigen-specific cellular responses in mice and protects guinea pigs in a model of latent infection.
J Microbiol Immunol Infect
; 48(6): 597-603, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24863497
5.
Preclinical study and phase I clinical safety evaluation of recombinant Mycobacterium tuberculosis ESAT6 protein.
Med Sci Monit Basic Res
; 19: 146-52, 2013 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23676766
6.
The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants.
FEMS Immunol Med Microbiol
; 59(1): 42-52, 2010 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20298499
Resultados
1 -
6
de 6
1
Próxima >
>>